Lv11
20 积分 2024-07-05 加入
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?
4天前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
4天前
已完结
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
6天前
已完结
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia
6天前
已完结
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk
10天前
已完结
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
10天前
已完结
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
11天前
已完结
Early administration of low molecular weight heparin in hypertriglyceridemia-induced acute pancreatitis: A propensity score-matched retrospective cohort study
26天前
已完结
Triglyceride Lowering Drugs
1个月前
已完结
How to Handle Elevated Triglycerides: Life after PROMINENT
1个月前
已完结
皖公网安备34019202002308
